Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KE Holdings Inc (BEKE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

KE Holdings IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

KE Holdings Inc vs Zimmer Biomet Holdings Inc — how do they compare? KE Holdings Inc trades at $17.34 (market cap $18.92B), while Zimmer Biomet Holdings Inc trades at $96.12 (market cap $18.55B). The key difference: KE Holdings Inc and Zimmer Biomet Holdings Inc are close in size by market cap, and KE Holdings Inc pays the higher dividend (1.63%). Which is the better fit depends on your goals.

BEKEZBH
Market Cap
$18.92B$18.55B
Sector
TechnologyHealth
52-Week High
$20.36$107.71
52-Week Low
$14.26$79.58
Enterprise Value
$14.66B$25.61B
Dividend Yield
1.63%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KE Holdings Inc

BEKE trades at $17.23, down 2.38% today, with a bullish technical signal supported by moving averages. The company reported strong Q1 2026 results, beating EPS estimates with $0.20 vs. $0.14 expected, while revenue declined to $90.1B in 2026 from $94.6B in 2025. Analyst sentiment remains overwhelmingly positive with 91.67% buy ratings. Cash flow trends show improvement with operating cash flow turning positive in 2026 at $2.1B.

The outlook appears favorable with improving profitability and strong analyst support, though risks include revenue contraction and China's property market exposure. The stock's current valuation at P/E 38.53 appears elevated but is supported by earnings growth potential and market leadership position in Chinese housing services.

Zimmer Biomet Holdings Inc

ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.

The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.

Returns comparison

Trailing returns across standard periods

About KE Holdings Inc

KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.

Read more on BEKE

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH